{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:04Z","timestamp":1791906424755,"version":"4.3.4"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374277"],"award-info":[{"award-number":["82374277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The global incidence and prevalence of kidney diseases continue to rise, posing a serious public health challenge. SIRT6 is an NAD\u207a-dependent histone deacetylase with broad essential regulatory roles across various pathophysiological processes, including DNA repair, chromatin accessibility, telomere stability, and glycolipid metabolism. As an epigenetic regulator specifically expressed in kidney tissues, SIRT6 serves as a central mediator of kidney homeostasis. Notably, accumulating evidence has implicated aberrant SIRT6 expression in the onset and development of various kidney diseases, such as acute kidney injury, diabetic kidney disease, hypertensive nephropathy, renal fibrosis, and renal cell carcinoma. In the present review, we provide an overview of the sirtuin family, systematically characterize the enzymatic activities and critical biological functions of SIRT6, and discuss its molecular mechanisms across various kidney diseases, focusing on its cell type-specific functions. We further summarize the latest research advances in SIRT6-targeted modulators for improving kidney diseases and analyze the challenges associated with their clinical application. Overall, we highlight SIRT6 as a highly promising novel target in the treatment and prevention of kidney diseases, with strong potential for clinical translation.<\/jats:p>","DOI":"10.1038\/s41420-026-03264-y","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:33:58Z","timestamp":1784313238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging roles of SIRT6 and its modulators in kidney diseases"],"prefix":"10.1038","volume":"12","author":[{"given":"Feihong","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3315-2276","authenticated-orcid":false,"given":"Yudian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8203-4178","authenticated-orcid":false,"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3951-214X","authenticated-orcid":false,"given":"Yongli","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"3264_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-5-224","volume":"5","author":"BJ North","year":"2004","unstructured":"North BJ, Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 2004;5:224.","journal-title":"Genome Biol"},{"key":"3264_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature08197","volume":"460","author":"T Finkel","year":"2009","unstructured":"Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460:587\u201391.","journal-title":"Nature"},{"key":"3264_CR3","doi-asserted-by":"publisher","first-page":"107984","DOI":"10.1016\/j.phrs.2025.107984","volume":"221","author":"RR Chen","year":"2025","unstructured":"Chen RR, Li YY, Wu JW, Wang Y, Song W, Shao D, et al. SIRT6 in health and diseases: From molecular mechanisms to therapeutic prospects. Pharm Res. 2025;221:107984.","journal-title":"Pharm Res"},{"key":"3264_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/ars.2017.7178","volume":"28","author":"N D\u2019Onofrio","year":"2018","unstructured":"D\u2019Onofrio N, Servillo L, Balestrieri ML. SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection. Antioxid Redox Signal. 2018;28:711\u201332.","journal-title":"Antioxid Redox Signal"},{"key":"3264_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-022-03455-1","volume":"13","author":"A Sharma","year":"2023","unstructured":"Sharma A, Mahur P, Muthukumaran J, Singh AK, Jain M. Shedding light on structure, function and regulation of human sirtuins: a comprehensive review. 3 Biotech. 2023;13:29.","journal-title":"3 Biotech"},{"key":"3264_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12031-017-1005-y","volume":"64","author":"NF Mohamad Nasir","year":"2018","unstructured":"Mohamad Nasir NF, Zainuddin A, Shamsuddin S. Emerging roles of sirtuin 6 in Alzheimer\u2019s disease. J Mol Neurosci. 2018;64:157\u201361.","journal-title":"J Mol Neurosci"},{"key":"3264_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.1202723","volume":"332","author":"Z Mao","year":"2011","unstructured":"Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science. 2011;332:1443\u20136.","journal-title":"Science"},{"key":"3264_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.molcel.2013.06.018","volume":"51","author":"D Toiber","year":"2013","unstructured":"Toiber D, Erdel F, Bouazoune K, Silberman DM, Zhong L, Mulligan P, et al. SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Mol Cell. 2013;51:454\u201368.","journal-title":"Mol Cell"},{"key":"3264_CR9","first-page":"521","volume":"18","author":"S Masri","year":"2015","unstructured":"Masri S. Sirtuin-dependent clock control: new advances in metabolism, aging and cancer. Curr Opin Clin Nutr Metab Care. 2015;18:521\u20137.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3264_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.7150\/ijbs.7.575","volume":"7","author":"X Li","year":"2011","unstructured":"Li X, Kazgan N. Mammalian sirtuins and energy metabolism. Int J Biol Sci. 2011;7:575\u201387.","journal-title":"Int J Biol Sci"},{"key":"3264_CR11","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1074\/jbc.M115.668699","volume":"291","author":"AS Madsen","year":"2016","unstructured":"Madsen AS, Andersen C, Daoud M, Anderson KA, Laursen JS, Chakladar S, et al. Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH. J Biol Chem. 2016;291:7128\u201341.","journal-title":"J Biol Chem"},{"key":"3264_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev-immunol-090122-045843","volume":"42","author":"O Foresto-Neto","year":"2024","unstructured":"Foresto-Neto O, Menezes-Silva L, Leite JA, Andrade-Silva M, C\u00e2mara NOS. Immunology of Kidney Disease. Annu Rev Immunol. 2024;42:207\u201333.","journal-title":"Annu Rev Immunol"},{"key":"3264_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13:629\u201346.","journal-title":"Nat Rev Nephrol"},{"key":"3264_CR14","doi-asserted-by":"publisher","first-page":"2482121","DOI":"10.1080\/0886022X.2025.2482121","volume":"47","author":"X Gao","year":"2025","unstructured":"Gao X, Liu X, Han Z, Liao H, Li R. Friend or foe? The role of SIRT6 on macrophage polarized to M2 subtype in acute kidney injury to chronic kidney disease. Ren Fail. 2025;47:2482121.","journal-title":"Ren Fail"},{"key":"3264_CR15","doi-asserted-by":"crossref","unstructured":"Jin Q, Li L, Qu P, Ma F, Li P, Qiao Y, et al. Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease-potential mechanisms involving epigenetic repression of inflammatory responses. J Adv Res. 2026;85:281\u2013294.","DOI":"10.1016\/j.jare.2025.10.008"},{"key":"3264_CR16","doi-asserted-by":"publisher","first-page":"1007168","DOI":"10.3389\/fphar.2022.1007168","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Li W, Zhang Z, Wang W, Huang H. SIRT6 overexpression retards renal interstitial fibrosis through targeting HIPK2 in chronic kidney disease. Front Pharm. 2022;13:1007168.","journal-title":"Front Pharm"},{"key":"3264_CR17","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMra1100831","volume":"364","author":"L Guarente","year":"2011","unstructured":"Guarente L. Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med. 2011;364:2235\u201344.","journal-title":"N Engl J Med"},{"key":"3264_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol. 2010;5:253\u201395.","journal-title":"Annu Rev Pathol"},{"key":"3264_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrneph.2017.5","volume":"13","author":"KA Hershberger","year":"2017","unstructured":"Hershberger KA, Martin AS, Hirschey MD. Role of NAD(+) and mitochondrial sirtuins in cardiac and renal diseases. Nat Rev Nephrol. 2017;13:213\u201325.","journal-title":"Nat Rev Nephrol"},{"key":"3264_CR20","doi-asserted-by":"publisher","first-page":"27629","DOI":"10.1074\/jbc.M109.030965","volume":"284","author":"R Graeff","year":"2009","unstructured":"Graeff R, Liu Q, Kriksunov IA, Kotaka M, Oppenheimer N, Hao Q, et al. Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38. J Biol Chem. 2009;284:27629\u201336.","journal-title":"J Biol Chem"},{"key":"3264_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molcel.2004.08.031","volume":"16","author":"A Vaquero","year":"2004","unstructured":"Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell. 2004;16:93\u2013105.","journal-title":"Mol Cell"},{"key":"3264_CR22","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/emboj\/21.10.2383","volume":"21","author":"E Langley","year":"2002","unstructured":"Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, et al. Human SIR2 deacetylates p53 and antagonizes PML\/p53-induced cellular senescence. EMBO J. 2002;21:2383\u201396.","journal-title":"EMBO J"},{"key":"3264_CR23","doi-asserted-by":"publisher","first-page":"e27081","DOI":"10.1371\/journal.pone.0027081","volume":"6","author":"X Zhu","year":"2011","unstructured":"Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, et al. Activation of Sirt1 by resveratrol inhibits TNF-\u03b1 induced inflammation in fibroblasts. PLoS One. 2011;6:e27081.","journal-title":"PLoS One"},{"key":"3264_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1126\/science.1169956","volume":"324","author":"EM Dioum","year":"2009","unstructured":"Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science. 2009;324:1289\u201393.","journal-title":"Science"},{"key":"3264_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nature02583","volume":"429","author":"F Picard","year":"2004","unstructured":"Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004;429:771\u20136.","journal-title":"Nature"},{"key":"3264_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tibs.2010.07.009","volume":"36","author":"RI Tennen","year":"2011","unstructured":"Tennen RI, Chua KF. Chromatin regulation and genome maintenance by mammalian SIRT6. Trends Biochem Sci. 2011;36:39\u201346.","journal-title":"Trends Biochem Sci"},{"key":"3264_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.18632\/aging.100011","volume":"1","author":"RA McCord","year":"2009","unstructured":"McCord RA, Michishita E, Hong T, Berber E, Boxer LD, Kusumoto R, et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY). 2009;1:109\u201321.","journal-title":"Aging (Albany NY)"},{"key":"3264_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00018-022-04342-x","volume":"79","author":"FA Lagunas-Rangel","year":"2022","unstructured":"Lagunas-Rangel FA. SIRT7 in the aging process. Cell Mol Life Sci. 2022;79:297.","journal-title":"Cell Mol Life Sci"},{"key":"3264_CR29","doi-asserted-by":"publisher","first-page":"M111.015156","DOI":"10.1074\/mcp.M111.015156","volume":"11","author":"YC Tsai","year":"2012","unstructured":"Tsai YC, Greco TM, Boonmee A, Miteva Y, Cristea IM. Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol Cell Proteom. 2012;11:M111.015156.","journal-title":"Mol Cell Proteom"},{"key":"3264_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35219-z","volume":"13","author":"T Yoshizawa","year":"2022","unstructured":"Yoshizawa T, Sato Y, Sobuz SU, Mizumoto T, Tsuyama T, Karim MF, et al. SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice. Nat Commun. 2022;13:7439.","journal-title":"Nat Commun"},{"key":"3264_CR31","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.arr.2019.100961","volume":"55","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang J, Hong T, Chen X, Cui L. SIRT2: Controversy and multiple roles in disease and physiology. Ageing Res Rev. 2019;55:100961.","journal-title":"Ageing Res Rev"},{"key":"3264_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10495-016-1341-3","volume":"22","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mu Y, Zhou X, Ji H, Gao X, Cai WW, et al. SIRT2-mediated FOXO3a deacetylation drives its nuclear translocation triggering FasL-induced cell apoptosis during renal ischemia reperfusion. Apoptosis. 2017;22:519\u201330.","journal-title":"Apoptosis"},{"key":"3264_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/hmg\/ddac218","volume":"32","author":"E Agborbesong","year":"2023","unstructured":"Agborbesong E, Zhou JX, Li LX, Harris PC, Calvet JP, Li X. Prdx5 regulates DNA damage response through autophagy-dependent Sirt2-p53 axis. Hum Mol Genet. 2023;32:567\u201379.","journal-title":"Hum Mol Genet"},{"key":"3264_CR34","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1128\/MCB.01636-07","volume":"27","author":"DB Lombard","year":"2007","unstructured":"Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 2007;27:8807\u201314.","journal-title":"Mol Cell Biol"},{"key":"3264_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1161\/HYPERTENSIONAHA.118.10482","volume":"72","author":"JR Lin","year":"2018","unstructured":"Lin JR, Zheng YJ, Zhang ZB, Shen WL, Li XD, Wei T, et al. Suppression of endothelial-to-mesenchymal transition by SIRT (sirtuin) 3 alleviated the development of hypertensive renal injury. Hypertension. 2018;72:350\u201360.","journal-title":"Hypertension"},{"key":"3264_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2016.10.016","volume":"167","author":"W Yang","year":"2016","unstructured":"Yang W, Nagasawa K, M\u00fcnch C, Xu Y, Satterstrom K, Jeong S, et al. Mitochondrial sirtuin network reveals dynamic SIRT3-dependent deacetylation in response to membrane depolarization. Cell. 2016;167:985\u20131000.e21.","journal-title":"Cell"},{"key":"3264_CR37","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1080\/10408398.2022.2070722","volume":"63","author":"S Pande","year":"2023","unstructured":"Pande S, Raisuddin S. Molecular and cellular regulatory roles of sirtuin protein. Crit Rev Food Sci Nutr. 2023;63:9895\u2013913.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3264_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05409-0","volume":"13","author":"X Yin","year":"2022","unstructured":"Yin X, Peng J, Gu L, Liu Y, Li X, Wu J, et al. Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis. Cell Death Dis. 2022;13:955.","journal-title":"Cell Death Dis"},{"key":"3264_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11427-016-0060-7","volume":"60","author":"L Yang","year":"2017","unstructured":"Yang L, Ma X, He Y, Yuan C, Chen Q, Li G, et al. Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors. Sci China Life Sci. 2017;60:249\u201356.","journal-title":"Sci China Life Sci"},{"key":"3264_CR40","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41418-021-00886-w","volume":"29","author":"X Liu","year":"2022","unstructured":"Liu X, Rong F, Tang J, Zhu C, Chen X, Jia S, et al. Repression of p53 function by SIRT5-mediated desuccinylation at Lysine 120 in response to DNA damage. Cell Death Differ. 2022;29:722\u201336.","journal-title":"Cell Death Differ"},{"key":"3264_CR41","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1096\/fj.13-245241","volume":"28","author":"M Buler","year":"2014","unstructured":"Buler M, Aatsinki SM, Izzi V, Uusimaa J, Hakkola andJ. SIRT5 is under the control of PGC-1\u03b1 and AMPK and is involved in regulation of mitochondrial energy metabolism. FASEB J. 2014;28:3225\u201337.","journal-title":"FASEB J"},{"key":"3264_CR42","first-page":"447","volume":"28","author":"U Mahlknecht","year":"2006","unstructured":"Mahlknecht U, Ho AD, Voelter-Mahlknecht S. Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int J Oncol. 2006;28:447\u201356.","journal-title":"Int J Oncol"},{"key":"3264_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.mad.2010.01.006","volume":"131","author":"RI Tennen","year":"2010","unstructured":"Tennen RI, Berber E, Chua KF. Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mech Ageing Dev. 2010;131:185\u201392.","journal-title":"Mech Ageing Dev"},{"key":"3264_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fphar.2012.00016","volume":"3","author":"S Moniot","year":"2012","unstructured":"Moniot S, Weyand M, Steegborn C. Structures, substrates, and regulators of Mammalian sirtuins - opportunities and challenges for drug development. Front Pharm. 2012;3:16.","journal-title":"Front Pharm"},{"key":"3264_CR45","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.bbapap.2009.09.009","volume":"1804","author":"BD Sanders","year":"2010","unstructured":"Sanders BD, Jackson B, Marmorstein R. Structural basis for sirtuin function: what we know and what we don\u2019t. Biochim Biophys Acta. 2010;1804:1604\u201316.","journal-title":"Biochim Biophys Acta"},{"key":"3264_CR46","doi-asserted-by":"publisher","first-page":"14575","DOI":"10.1074\/jbc.M111.218990","volume":"286","author":"PW Pan","year":"2011","unstructured":"Pan PW, Feldman JL, Devries MK, Dong A, Edwards AM, Denu JM. Structure and biochemical functions of SIRT6. J Biol Chem. 2011;286:14575\u201387.","journal-title":"J Biol Chem"},{"key":"3264_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature12038","volume":"496","author":"H Jiang","year":"2013","unstructured":"Jiang H, Khan S, Wang Y, Charron G, He B, Sebastian C, et al. SIRT6 regulates TNF-\u03b1 secretion through hydrolysis of long-chain fatty acyl lysine. Nature. 2013;496:110\u20133.","journal-title":"Nature"},{"key":"3264_CR48","doi-asserted-by":"publisher","first-page":"31350","DOI":"10.1074\/jbc.C113.511261","volume":"288","author":"JL Feldman","year":"2013","unstructured":"Feldman JL, Baeza J, Denu JM. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J Biol Chem. 2013;288:31350\u20136.","journal-title":"J Biol Chem"},{"key":"3264_CR49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","volume":"23","author":"G Mill\u00e1n-Zambrano","year":"2022","unstructured":"Mill\u00e1n-Zambrano G, Burton A, Bannister AJ, Schneider R. Histone post-translational modifications - cause and consequence of genome function. Nat Rev Genet. 2022;23:563\u201380.","journal-title":"Nat Rev Genet"},{"key":"3264_CR50","doi-asserted-by":"publisher","first-page":"108446","DOI":"10.1016\/j.jbc.2025.108446","volume":"301","author":"ZA Wang","year":"2025","unstructured":"Wang ZA, Markert J, Whedon SD, Abeywardana MY, Sheng X, Nam E, et al. Structural and enzymatic plasticity of SIRT6 deacylase activity. J Biol Chem. 2025;301:108446.","journal-title":"J Biol Chem"},{"key":"3264_CR51","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature06736","volume":"452","author":"E Michishita","year":"2008","unstructured":"Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452:492\u20136.","journal-title":"Nature"},{"key":"3264_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2008.10.052","volume":"136","author":"TL Kawahara","year":"2009","unstructured":"Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell. 2009;136:62\u201374.","journal-title":"Cell"},{"key":"3264_CR53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cell.2009.12.041","volume":"140","author":"L Zhong","year":"2010","unstructured":"Zhong L, D\u2019Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell. 2010;140:280\u201393.","journal-title":"Cell"},{"key":"3264_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00498-4","volume":"8","author":"M Liu","year":"2017","unstructured":"Liu M, Liang K, Zhen J, Zhou M, Wang X, Wang Z, et al. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat Commun. 2017;8:413.","journal-title":"Nat Commun"},{"key":"3264_CR55","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.118.314032","volume":"124","author":"J Guo","year":"2019","unstructured":"Guo J, Wang Z, Wu J, Liu M, Li M, Sun Y, et al. Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling. Circ Res. 2019;124:1448\u201361.","journal-title":"Circ Res"},{"key":"3264_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1377","volume":"13","author":"Z Guo","year":"2023","unstructured":"Guo Z, Yu X, Zhao S, Zhong X, Huang D, Feng R, et al. SIRT6 deficiency in endothelial cells exacerbates oxidative stress by enhancing HIF1\u03b1 accumulation and H3K9 acetylation at the Ero1\u03b1 promoter. Clin Transl Med. 2023;13:e1377.","journal-title":"Clin Transl Med"},{"key":"3264_CR57","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.4161\/cc.8.16.9367","volume":"8","author":"E Michishita","year":"2009","unstructured":"Michishita E, McCord RA, Boxer LD, Barber MF, Hong T, Gozani O, et al. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle. 2009;8:2664\u20136.","journal-title":"Cell Cycle"},{"key":"3264_CR58","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.molcel.2019.06.034","volume":"75","author":"JP Etchegaray","year":"2019","unstructured":"Etchegaray JP, Zhong L, Li C, Henriques T, Ablondi E, Nakadai T, et al. The histone deacetylase SIRT6 restrains transcription elongation via promoter-proximal pausing. Mol Cell. 2019;75:683\u2013.e7.","journal-title":"Mol Cell"},{"key":"3264_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-023-01456-x","volume":"8","author":"YN Ding","year":"2023","unstructured":"Ding YN, Wang TT, Lv SJ, Tang X, Wei ZY, Yao F, et al. SIRT6 is an epigenetic repressor of thoracic aortic aneurysms via inhibiting inflammation and senescence. Signal Transduct Target Ther. 2023;8:255.","journal-title":"Signal Transduct Target Ther"},{"key":"3264_CR60","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nsmb.3202","volume":"23","author":"L Tasselli","year":"2016","unstructured":"Tasselli L, Xi Y, Zheng W, Tennen RI, Odrowaz Z, Simeoni F, et al. SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence. Nat Struct Mol Biol. 2016;23:434\u201340.","journal-title":"Nat Struct Mol Biol"},{"key":"3264_CR61","doi-asserted-by":"publisher","first-page":"E538","DOI":"10.1073\/pnas.1520045113","volume":"113","author":"A Bhardwaj","year":"2016","unstructured":"Bhardwaj A, Das S. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions. Proc Natl Acad Sci USA. 2016;113:E538\u201347.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3264_CR62","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbrc.2017.02.111","volume":"485","author":"NN Tao","year":"2017","unstructured":"Tao NN, Ren JH, Tang H, Ran LK, Zhou HZ, Liu B, et al. Deacetylation of Ku70 by SIRT6 attenuates Bax-mediated apoptosis in hepatocellular carcinoma. Biochem Biophys Res Commun. 2017;485:713\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3264_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35424-w","volume":"13","author":"ML Ji","year":"2022","unstructured":"Ji ML, Jiang H, Li Z, Geng R, Hu JZ, Lin YC, et al. Sirt6 attenuates chondrocyte senescence and osteoarthritis progression. Nat Commun. 2022;13:7658.","journal-title":"Nat Commun"},{"key":"3264_CR64","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/hep.31418","volume":"73","author":"J Zhang","year":"2021","unstructured":"Zhang J, Li Y, Liu Q, Huang Y, Li R, Wu T, et al. Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells. Hepatology. 2021;73:1140\u201357.","journal-title":"Hepatology"},{"key":"3264_CR65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jcmgh.2020.04.005","volume":"10","author":"X Zhong","year":"2020","unstructured":"Zhong X, Huang M, Kim HG, Zhang Y, Chowdhury K, Cai W, et al. SIRT6 protects against liver fibrosis by deacetylation and suppression of SMAD3 in hepatic stellate cells. Cell Mol Gastroenterol Hepatol. 2020;10:341\u201364.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3264_CR66","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.molcel.2012.09.030","volume":"48","author":"JE Dominy Jr","year":"2012","unstructured":"Dominy JE Jr, Lee Y, Jedrychowski MP, Chim H, Jurczak MJ, et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol Cell. 2012;48:900\u201313.","journal-title":"Mol Cell"},{"key":"3264_CR67","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1096\/fj.201800321R","volume":"33","author":"G Sociali","year":"2019","unstructured":"Sociali G, Grozio A, Caffa I, Schuster S, Becherini P, Damonte P, et al. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells. FASEB J. 2019;33:3704\u201317.","journal-title":"FASEB J"},{"key":"3264_CR68","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.bbrc.2018.10.017","volume":"505","author":"W Li","year":"2018","unstructured":"Li W, Zhu Y, Liu X, Hou J, Fang J, Shen J, et al. Phencynonate mediates antidepressant response by activating sirtuin 6-SOD2\/Prdx6 pathway. Biochem Biophys Res Commun. 2018;505:898\u2013904.","journal-title":"Biochem Biophys Res Commun"},{"key":"3264_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44179-x","volume":"14","author":"J Quan","year":"2023","unstructured":"Quan J, Wen X, Su G, Zhong Y, Huang T, Xiong Z, et al. Epithelial SIRT6 governs IL-17A pathogenicity and drives allergic airway inflammation and remodeling. Nat Commun. 2023;14:8525.","journal-title":"Nat Commun"},{"key":"3264_CR70","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41418-024-01412-4","volume":"32","author":"F Chen","year":"2025","unstructured":"Chen F, Xu W, Tang M, Tian Y, Shu Y, He X, et al. hnRNPA2B1 deacetylation by SIRT6 restrains local transcription and safeguards genome stability. Cell Death Differ. 2025;32:382\u201396.","journal-title":"Cell Death Differ"},{"key":"3264_CR71","doi-asserted-by":"publisher","first-page":"115439","DOI":"10.1016\/j.bcp.2023.115439","volume":"209","author":"J Wang","year":"2023","unstructured":"Wang J, Liu Z, Lu J, Zou J, Ye W, Li H, et al. SIRT6 regulates endothelium-dependent relaxation by modulating nitric oxide synthase 3 (NOS3). Biochem Pharm. 2023;209:115439.","journal-title":"Biochem Pharm"},{"key":"3264_CR72","doi-asserted-by":"publisher","first-page":"42419","DOI":"10.1074\/jbc.R112.378877","volume":"287","author":"JL Feldman","year":"2012","unstructured":"Feldman JL, Dittenhafer-Reed KE, Denu JM. Sirtuin catalysis and regulation. J Biol Chem. 2012;287:42419\u201327.","journal-title":"J Biol Chem"},{"key":"3264_CR73","doi-asserted-by":"publisher","first-page":"21313","DOI":"10.1074\/jbc.M413296200","volume":"280","author":"G Liszt","year":"2005","unstructured":"Liszt G, Ford E, Kurtev M, Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem. 2005;280:21313\u201320.","journal-title":"J Biol Chem"},{"key":"3264_CR74","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.4161\/cc.10.18.17435","volume":"10","author":"M Van Meter","year":"2011","unstructured":"Van Meter M, Mao Z, Gorbunova V, Seluanov A. SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle. 2011;10:3153\u20138.","journal-title":"Cell Cycle"},{"key":"3264_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6011","volume":"5","author":"M Van Meter","year":"2014","unstructured":"Van Meter M, Kashyap M, Rezazadeh S, Geneva AJ, Morello TD, Seluanov A, et al. SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age. Nat Commun. 2014;5:5011.","journal-title":"Nat Commun"},{"key":"3264_CR76","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.1093\/nar\/gkz528","volume":"47","author":"S Rezazadeh","year":"2019","unstructured":"Rezazadeh S, Yang D, Tombline G, Simon M, Regan SP, Seluanov A, et al. SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170. Nucleic Acids Res. 2019;47:7914\u201328.","journal-title":"Nucleic Acids Res"},{"key":"3264_CR77","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.18632\/aging.103567","volume":"12","author":"S Rezazadeh","year":"2020","unstructured":"Rezazadeh S, Yang D, Biashad SA, Firsanov D, Takasugi M, Gilbert M, et al. SIRT6 mono-ADP ribosylates KDM2A to locally increase H3K36me2 at DNA damage sites to inhibit transcription and promote repair. Aging (Albany NY). 2020;12:11165\u201384.","journal-title":"Aging (Albany NY)"},{"key":"3264_CR78","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110393","volume":"41","author":"M Simon","year":"2022","unstructured":"Simon M, Yang J, Gigas J, Earley EJ, Hillpot E, Zhang L, et al. A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A. EMBO J. 2022;41:e110393.","journal-title":"EMBO J"},{"key":"3264_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406390","volume":"11","author":"W Zhang","year":"2024","unstructured":"Zhang W, Bai L, Xu W, Liu J, Chen Y, Lin W, et al. Sirt6 mono-ADP-ribosylates YY1 to promote dystrophin expression for neuromuscular transmission. Adv Sci (Weinh). 2024;11:e2406390.","journal-title":"Adv Sci (Weinh)"},{"key":"3264_CR80","doi-asserted-by":"crossref","unstructured":"Affandi T, Haas A, Ohm AM, Wright GM, Black JC, Reyland ME. PKC\u03b4 regulates chromatin remodeling and DNA repair through SIRT6. Mol Cancer Res. 2024;22:181\u2013196.","DOI":"10.1158\/1541-7786.MCR-23-0493"},{"key":"3264_CR81","doi-asserted-by":"crossref","unstructured":"Robbins P, Zhang L, Elsallabi O, Soto-Palma C, Bartz J, Salekeen R, et al. Fucoidans are senotherapeutics that enhance SIRT6-dependent DNA repair. Res Sq. 2025;rs.3.rs\u20136613032.","DOI":"10.21203\/rs.3.rs-6613032\/v1"},{"key":"3264_CR82","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nchembio.2106","volume":"12","author":"X Zhang","year":"2016","unstructured":"Zhang X, Khan S, Jiang H, Antonyak MA, Chen X, Spiegelman NA, et al. Identifying the functional contribution of the defatty-acylase activity of SIRT6. Nat Chem Biol. 2016;12:614\u201320.","journal-title":"Nat Chem Biol"},{"key":"3264_CR83","doi-asserted-by":"crossref","unstructured":"Zhang, X, Spiegelman NA, Nelson OD, Jing H, Lin H. SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation. Elife. 2017;6:e25158.","DOI":"10.7554\/eLife.25158"},{"key":"3264_CR84","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1021\/acschembio.6b00243","volume":"11","author":"WW Wang","year":"2016","unstructured":"Wang WW, Zeng Y, Wu B, Deiters A, Liu WR. A chemical biology approach to reveal Sirt6-targeted histone H3 sites in nucleosomes. ACS Chem Biol. 2016;11:1973\u201381.","journal-title":"ACS Chem Biol"},{"key":"3264_CR85","doi-asserted-by":"publisher","first-page":"106424","DOI":"10.1016\/j.ejps.2023.106424","volume":"185","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Sun W, Zhang G, Fang Z, Chen X, Li L. Design, synthesis, and biological screening of a series of pyrazolo [1,5-a]quina-zoline derivatives as SIRT6 activators. Eur J Pharm Sci. 2023;185:106424.","journal-title":"Eur J Pharm Sci"},{"key":"3264_CR86","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.cell.2019.03.043","volume":"177","author":"X Tian","year":"2019","unstructured":"Tian X, Firsanov D, Zhang Z, Cheng Y, Luo L, Tombline G, et al. SIRT6 is responsible for more efficient DNA double-strand break repair in long-lived species. Cell. 2019;177:622\u2013.e22.","journal-title":"Cell"},{"key":"3264_CR87","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2005.11.044","volume":"124","author":"R Mostoslavsky","year":"2006","unstructured":"Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006;124:315\u201329.","journal-title":"Cell"},{"key":"3264_CR88","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.celrep.2016.08.006","volume":"16","author":"M Van Meter","year":"2016","unstructured":"Van Meter M, Simon M, Tombline G, May A, Morello TD, Hubbard BP, et al. JNK Phosphorylates SIRT6 to stimulate DNA double-strand break repair in response to oxidative stress by recruiting PARP1 to DNA breaks. Cell Rep. 2016;16:2641\u201350.","journal-title":"Cell Rep"},{"key":"3264_CR89","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1016\/j.celrep.2015.11.054","volume":"13","author":"Y Atsumi","year":"2015","unstructured":"Atsumi Y, Minakawa Y, Ono M, Dobashi S, Shinohe K, Shinohara A, et al. ATM and SIRT6\/SNF2H mediate transient H2AX stabilization when DSBs form by blocking HUWE1 to allow efficient \u03b3H2AX foci formation. Cell Rep. 2015;13:2728\u201340.","journal-title":"Cell Rep"},{"key":"3264_CR90","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1016\/j.celrep.2017.02.082","volume":"18","author":"W Chen","year":"2017","unstructured":"Chen W, Liu N, Zhang H, Zhang H, Qiao J, Jia W, et al. Sirt6 promotes DNA end joining in iPSCs derived from old mice. Cell Rep. 2017;18:2880\u201392.","journal-title":"Cell Rep"},{"key":"3264_CR91","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4161\/15384101.2014.980641","volume":"14","author":"Z Xu","year":"2015","unstructured":"Xu Z, Zhang L, Zhang W, Meng D, Zhang H, Jiang Y, et al. SIRT6 rescues the age related decline in base excision repair in a PARP1-dependent manner. Cell Cycle. 2015;14:269\u201376.","journal-title":"Cell Cycle"},{"key":"3264_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12867-015-0041-9","volume":"16","author":"BJ Hwang","year":"2015","unstructured":"Hwang BJ, Jin J, Gao Y, Shi G, Madabushi A, Yan A, et al. SIRT6 protein deacetylase interacts with MYH DNA glycosylase, APE1 endonuclease, and Rad9-Rad1-Hus1 checkpoint clamp. BMC Mol Biol. 2015;16:12.","journal-title":"BMC Mol Biol"},{"key":"3264_CR93","doi-asserted-by":"publisher","first-page":"9181","DOI":"10.1093\/nar\/gkaa661","volume":"48","author":"A Geng","year":"2020","unstructured":"Geng A, Tang H, Huang J, Qian Z, Qin N, Yao Y, et al. The deacetylase SIRT6 promotes the repair of UV-induced DNA damage by targeting DDB2. Nucleic Acids Res. 2020;48:9181\u201394.","journal-title":"Nucleic Acids Res"},{"key":"3264_CR94","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.cell.2013.02.011","volume":"152","author":"BD Price","year":"2013","unstructured":"Price BD, D\u2019Andrea AD. Chromatin remodeling at DNA double-strand breaks. Cell. 2013;152:1344\u201354.","journal-title":"Cell"},{"key":"3264_CR95","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/19491034.2022.2143106","volume":"13","author":"AR Mansisidor","year":"2022","unstructured":"Mansisidor AR, Risca VI. Chromatin accessibility: methods, mechanisms, and biological insights. Nucleus. 2022;13:236\u201376.","journal-title":"Nucleus"},{"key":"3264_CR96","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol. 2014;15:703\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3264_CR97","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2008.10.009","volume":"32","author":"MA Cohn","year":"2008","unstructured":"Cohn MA, D\u2019Andrea AD. Chromatin recruitment of DNA repair proteins: lessons from the fanconi anemia and double-strand break repair pathways. Mol Cell. 2008;32:306\u201312.","journal-title":"Mol Cell"},{"key":"3264_CR98","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/nar\/gkaa006","volume":"48","author":"T Hou","year":"2020","unstructured":"Hou T, Cao Z, Zhang J, Tang M, Tian Y, Li Y, et al. SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair. Nucleic Acids Res. 2020;48:2982\u20133000.","journal-title":"Nucleic Acids Res"},{"key":"3264_CR99","doi-asserted-by":"publisher","first-page":"103736","DOI":"10.1016\/j.redox.2025.103736","volume":"85","author":"K Pang","year":"2025","unstructured":"Pang K, Huang J, Zhang S, Guan Y, Zou N, Kang J, et al. Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy. Redox Biol. 2025;85:103736.","journal-title":"Redox Biol"},{"key":"3264_CR100","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.molmet.2015.09.003","volume":"4","author":"JG Anderson","year":"2015","unstructured":"Anderson JG, Ramadori G, Ioris RM, Gali\u00e8 M, Berglund ED, Coate KC, et al. Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6. Mol Metab. 2015;4:846\u201356.","journal-title":"Mol Metab"},{"key":"3264_CR101","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00125-015-3778-2","volume":"59","author":"X Xiong","year":"2016","unstructured":"Xiong X, Wang G, Tao R, Wu P, Kono T, Li K, et al. Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells. Diabetologia. 2016;59:151\u201360.","journal-title":"Diabetologia"},{"key":"3264_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/srep30321","volume":"6","author":"MY Song","year":"2016","unstructured":"Song MY, Wang J, Ka SO, Bae EJ, Park BH. Insulin secretion impairment in Sirt6 knockout pancreatic \u03b2 cells is mediated by suppression of the FoxO1-Pdx1-Glut2 pathway. Sci Rep. 2016;6:30321.","journal-title":"Sci Rep"},{"key":"3264_CR103","doi-asserted-by":"publisher","first-page":"36776","DOI":"10.1074\/jbc.M110.168039","volume":"285","author":"C Xiao","year":"2010","unstructured":"Xiao C, Kim HS, Lahusen T, Wang RH, Xu X, Gavrilova O, et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem. 2010;285:36776\u201384.","journal-title":"J Biol Chem"},{"key":"3264_CR104","doi-asserted-by":"publisher","first-page":"116558","DOI":"10.1016\/j.lfs.2019.116558","volume":"231","author":"W Tang","year":"2019","unstructured":"Tang W, Fan Y. SIRT6 as a potential target for treating insulin resistance. Life Sci. 2019;231:116558.","journal-title":"Life Sci"},{"key":"3264_CR105","doi-asserted-by":"publisher","first-page":"18615","DOI":"10.1002\/jcp.28500","volume":"234","author":"C Tang","year":"2019","unstructured":"Tang C, Liu P, Zhou Y, Jiang B, Song Y, Sheng L. Sirt6 deletion in hepatocytes increases insulin sensitivity of female mice by enhancing ER\u03b1 expression. J Cell Physiol. 2019;234:18615\u201325.","journal-title":"J Cell Physiol"},{"key":"3264_CR106","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1073\/pnas.1411026111","volume":"111","author":"P Zhang","year":"2014","unstructured":"Zhang P, Tu B, Wang H, Cao Z, Tang M, Zhang C, et al. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc Natl Acad Sci USA. 2014;111:10684\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3264_CR107","doi-asserted-by":"publisher","first-page":"111597","DOI":"10.1016\/j.mce.2022.111597","volume":"547","author":"C Bian","year":"2022","unstructured":"Bian C, Zhang R, Wang Y, Li J, Song Y, Guo D, et al. Sirtuin 6 affects glucose reabsorption and gluconeogenesis in type 1 diabetes via FoxO1. Mol Cell Endocrinol. 2022;547:111597.","journal-title":"Mol Cell Endocrinol"},{"key":"3264_CR108","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","volume":"12","author":"HS Kim","year":"2010","unstructured":"Kim HS, Xiao C, Wang RH, Lahusen T, Xu X, Vassilopoulos A, et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010;12:224\u201336.","journal-title":"Cell Metab"},{"key":"3264_CR109","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1474-9726.2009.00544.x","volume":"9","author":"Y Kanfi","year":"2010","unstructured":"Kanfi Y, Peshti V, Gil R, Naiman S, Nahum L, Levin E, et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell. 2010;9:162\u201373.","journal-title":"Aging Cell"},{"key":"3264_CR110","doi-asserted-by":"publisher","first-page":"1244705","DOI":"10.3389\/fendo.2023.1244705","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu T, Cai Y, Liu W, Guo J. SIRT6\u2019s function in controlling the metabolism of lipids and glucose in diabetic nephropathy. Front Endocrinol (Lausanne). 2023;14:1244705.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3264_CR111","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.celrep.2013.08.006","volume":"4","author":"S Elhanati","year":"2013","unstructured":"Elhanati S, Kanfi Y, Varvak A, Roichman A, Carmel-Gross I, Barth S, et al. Multiple regulatory layers of SREBP1\/2 by SIRT6. Cell Rep. 2013;4:905\u201312.","journal-title":"Cell Rep"},{"key":"3264_CR112","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1194\/jlr.M039339","volume":"54","author":"R Tao","year":"2013","unstructured":"Tao R, Xiong X, DePinho RA, Deng CX, Dong XC. Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. J Lipid Res. 2013;54:2745\u201353.","journal-title":"J Lipid Res"},{"key":"3264_CR113","doi-asserted-by":"publisher","first-page":"166249","DOI":"10.1016\/j.bbadis.2021.166249","volume":"1867","author":"C Zhu","year":"2021","unstructured":"Zhu C, Huang M, Kim HG, Chowdhury K, Gao J, Liu S, et al. SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166249.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3264_CR114","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1016\/j.celrep.2019.11.067","volume":"29","author":"S Naiman","year":"2019","unstructured":"Naiman S, Huynh FK, Gil R, Glick Y, Shahar Y, Touitou N, et al. SIRT6 promotes hepatic beta-oxidation via activation of PPAR\u03b1. Cell Rep. 2019;29:4127\u2013.e8.","journal-title":"Cell Rep"},{"key":"3264_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0984-0","volume":"9","author":"M Li","year":"2018","unstructured":"Li M, Hou T, Gao T, Lu X, Yang Q, Zhu Q, et al. p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis. Cell Death Dis. 2018;9:941.","journal-title":"Cell Death Dis"},{"key":"3264_CR116","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2337\/db16-1225","volume":"66","author":"J Kuang","year":"2017","unstructured":"Kuang J, Zhang Y, Liu Q, Shen J, Pu S, Cheng S, et al. Fat-specific Sirt6 ablation sensitizes mice to high-fat diet-induced obesity and insulin resistance by inhibiting lipolysis. Diabetes. 2017;66:1159\u201371.","journal-title":"Diabetes"},{"key":"3264_CR117","doi-asserted-by":"publisher","first-page":"100994","DOI":"10.1016\/j.molmet.2020.100994","volume":"37","author":"Q Tang","year":"2020","unstructured":"Tang Q, Gao Y, Liu Q, Yang X, Wu T, Huang C, et al. Sirt6 in pro-opiomelanocortin neurons controls energy metabolism by modulating leptin signaling. Mol Metab. 2020;37:100994.","journal-title":"Mol Metab"},{"key":"3264_CR118","doi-asserted-by":"publisher","first-page":"e21408","DOI":"10.1096\/fj.202002607","volume":"35","author":"Q Tang","year":"2021","unstructured":"Tang Q, Liu Q, Yang X, Wu T, Huang C, Zhang J, et al. Sirtuin 6 supra-physiological overexpression in hypothalamic pro-opiomelanocortin neurons promotes obesity via the hypothalamus-adipose axis. Faseb j. 2021;35:e21408.","journal-title":"Faseb j"},{"key":"3264_CR119","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.celrep.2017.06.069","volume":"20","author":"L Yao","year":"2017","unstructured":"Yao L, Cui X, Chen Q, Yang X, Fang F, Zhang J, et al. Cold-inducible SIRT6 regulates thermogenesis of brown and beige fat. Cell Rep. 2017;20:641\u201354.","journal-title":"Cell Rep"},{"key":"3264_CR120","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.molcel.2019.07.023","volume":"75","author":"SM Jung","year":"2019","unstructured":"Jung SM, Hung CM, Hildebrand SR, Sanchez-Gurmaches J, Martinez-Pastor B, Gengatharan JM, et al. Non-canonical mTORC2 signaling regulates brown adipocyte lipid catabolism through SIRT6-FoxO1. Mol Cell. 2019;75:807\u2013.e8.","journal-title":"Mol Cell"},{"key":"3264_CR121","doi-asserted-by":"publisher","first-page":"eadl6441","DOI":"10.1126\/scisignal.adl6441","volume":"18","author":"W Wang","year":"2025","unstructured":"Wang W, Liang J, Zhang Y, Wang J, Miao X, Chang Y, et al. Myeloid sirtuin 6 deficiency causes obesity in mice by inducing norepinephrine degradation to limit thermogenic tissue function. Sci Signal. 2025;18:eadl6441.","journal-title":"Sci Signal"},{"key":"3264_CR122","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(24)02385-7","volume":"405","author":"M Ostermann","year":"2025","unstructured":"Ostermann M, Lumlertgul N, Jeong R, See E, Joannidis M, James M. Acute kidney injury. Lancet. 2025;405:241\u201356.","journal-title":"Lancet"},{"key":"3264_CR123","doi-asserted-by":"publisher","first-page":"111479","DOI":"10.1016\/j.cellsig.2024.111479","volume":"125","author":"S Yang","year":"2025","unstructured":"Yang S, Chen L, Din S, Ye Z, Zhou X, Cheng F, et al. The SIRT6\/BAP1\/xCT signaling axis mediates ferroptosis in cisplatin-induced AKI. Cell Signal. 2025;125:111479.","journal-title":"Cell Signal"},{"key":"3264_CR124","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.kint.2017.10.021","volume":"93","author":"Z Li","year":"2018","unstructured":"Li Z, Xu K, Zhang N, Amador G, Wang Y, Zhao S, et al. Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1\/2 signaling. Kidney Int. 2018;93:881\u201392.","journal-title":"Kidney Int"},{"key":"3264_CR125","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/15384101.2019.1568746","volume":"18","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang L, Meng L, Cao G, Wu Y. Sirtuin 6 overexpression relieves sepsis-induced acute kidney injury by promoting autophagy. Cell Cycle. 2019;18:425\u201336.","journal-title":"Cell Cycle"},{"key":"3264_CR126","doi-asserted-by":"publisher","first-page":"111757","DOI":"10.1016\/j.cellsig.2025.111757","volume":"131","author":"D Wang","year":"2025","unstructured":"Wang D, Zhou Y, Yang N, Liu J, Lu L, Gao Z. SIRT6 mitigates acute kidney injury by enhancing lipid metabolism and reducing tubular epithelial cell apoptosis via suppression of the ACMSD signaling pathway. Cell Signal. 2025;131:111757.","journal-title":"Cell Signal"},{"key":"3264_CR127","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12950-021-00291-7","volume":"18","author":"F Gao","year":"2021","unstructured":"Gao F, Qian M, Liu G, Ao W, Dai D, Yin C. USP10 alleviates sepsis-induced acute kidney injury by regulating Sirt6-mediated Nrf2\/ARE signaling pathway. J Inflamm (Lond). 2021;18:25.","journal-title":"J Inflamm (Lond)"},{"key":"3264_CR128","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1002\/jcp.29235","volume":"235","author":"Z Gao","year":"2020","unstructured":"Gao Z, Chen X, Fan Y, Zhu K, Shi M, Ding G. Sirt6 attenuates hypoxia-induced tubular epithelial cell injury via targeting G2\/M phase arrest. J Cell Physiol. 2020;235:3463\u201373.","journal-title":"J Cell Physiol"},{"key":"3264_CR129","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10565-020-09528-2","volume":"37","author":"KY So","year":"2021","unstructured":"So KY, Park BH, Oh SH. Cytoplasmic sirtuin 6 translocation mediated by p62 polyubiquitination plays a critical role in cadmium-induced kidney toxicity. Cell Biol Toxicol. 2021;37:193\u2013207.","journal-title":"Cell Biol Toxicol"},{"key":"3264_CR130","first-page":"111897","volume":"830","author":"X Feng","year":"2025","unstructured":"Feng X, Liu Y, Su L, Xu L. SIRT6 regulates the HIPK2\/P53 pathway to reduce oxidative stress and apoptosis to attenuate vancomycin-induced nephrotoxicity. Mutat Res. 2025;830:111897.","journal-title":"Mutat Res"},{"key":"3264_CR131","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/JCI72271","volume":"124","author":"K Reidy","year":"2014","unstructured":"Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124:2333\u201340.","journal-title":"J Clin Invest"},{"key":"3264_CR132","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248\u201360.","journal-title":"Kidney Int"},{"key":"3264_CR133","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3264_CR134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/PAP.0000000000000257","volume":"27","author":"M Akhtar","year":"2020","unstructured":"Akhtar M, Taha NM, Nauman A, Mujeeb IB, Al-Nabet A. Diabetic kidney disease: past and present. Adv Anat Pathol. 2020;27:87\u201397.","journal-title":"Adv Anat Pathol"},{"key":"3264_CR135","doi-asserted-by":"publisher","first-page":"701","DOI":"10.7150\/ijbs.29323","volume":"15","author":"Y Fan","year":"2019","unstructured":"Fan Y, Yang Q, Yang Y, Gao Z, Ma Y, Zhang L, et al. Sirt6 suppresses high glucose-induced mitochondrial dysfunction and apoptosis in podocytes through AMPK activation. Int J Biol Sci. 2019;15:701\u201313.","journal-title":"Int J Biol Sci"},{"key":"3264_CR136","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10863-024-10049-4","volume":"57","author":"P Ma","year":"2025","unstructured":"Ma P, Shao H, Xu D, Qi X. Sirt6 regulates the Notch signaling pathway and mediates autophagy and regulates podocyte damage in diabetic nephropathy. J Bioenerg Biomembr. 2025;57:49\u201355.","journal-title":"J Bioenerg Biomembr"},{"key":"3264_CR137","first-page":"103","volume":"55","author":"L Ji","year":"2019","unstructured":"Ji L, Chen Y, Wang H, Zhang W, He L, Wu J, et al. Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy. Int J Oncol. 2019;55:103\u201315.","journal-title":"Int J Oncol"},{"key":"3264_CR138","doi-asserted-by":"publisher","first-page":"2377785","DOI":"10.1080\/0886022X.2024.2377785","volume":"46","author":"L Du","year":"2024","unstructured":"Du L, Guo C, Zeng S, Yu K, Liu M, Li Y. Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2\/GPX4 pathway. Ren Fail. 2024;46:2377785.","journal-title":"Ren Fail"},{"key":"3264_CR139","doi-asserted-by":"publisher","first-page":"2410396","DOI":"10.1080\/0886022X.2024.2410396","volume":"46","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Huang H, Tao Y, Liu H, Fan Y. Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K\/AKT signaling pathway. Ren Fail. 2024;46:2410396.","journal-title":"Ren Fail"},{"key":"3264_CR140","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1681\/ASN.2020081188","volume":"32","author":"I Yasuda","year":"2021","unstructured":"Yasuda I, Hasegawa K, Sakamaki Y, Muraoka H, Kawaguchi T, Kusahana E, et al. Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy. J Am Soc Nephrol. 2021;32:1355\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"3264_CR141","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.celrep.2019.03.024","volume":"27","author":"H Muraoka","year":"2019","unstructured":"Muraoka H, Hasegawa K, Sakamaki Y, Minakuchi H, Kawaguchi T, Yasuda I, et al. Role of Nampt-Sirt6 axis in renal proximal tubules in extracellular matrix deposition in diabetic nephropathy. Cell Rep. 2019;27:199\u2013212.e5.","journal-title":"Cell Rep"},{"key":"3264_CR142","doi-asserted-by":"publisher","first-page":"5565761","DOI":"10.1155\/2021\/5565761","volume":"2021","author":"X Wang","year":"2021","unstructured":"Wang X, Ji T, Li X, Qu X, Bai S. FOXO3a protects against kidney injury in type II diabetic nephropathy by promoting Sirt6 expression and inhibiting Smad3 acetylation. Oxid Med Cell Longev. 2021;2021:5565761.","journal-title":"Oxid Med Cell Longev"},{"key":"3264_CR143","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00011-021-01485-8","volume":"70","author":"J Liu","year":"2021","unstructured":"Liu J, Duan P, Xu C, Xu D, Liu Y, Jiang J. CircRNA circ-ITCH improves renal inflammation and fibrosis in streptozotocin-induced diabetic mice by regulating the miR-33a-5p\/SIRT6 axis. Inflamm Res. 2021;70:835\u201346.","journal-title":"Inflamm Res"},{"key":"3264_CR144","doi-asserted-by":"crossref","unstructured":"Niculae A, Gherghina ME, Peride I, Tiglis M, Nechita AM, Checherita IA. Pathway from acute kidney injury to chronic kidney disease: molecules involved in renal fibrosis. Int J Mol Sci. 2023;24:14019.","DOI":"10.3390\/ijms241814019"},{"key":"3264_CR145","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8:129.","journal-title":"Signal Transduct Target Ther"},{"key":"3264_CR146","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-022-00828-9","volume":"29","author":"JH Chen","year":"2022","unstructured":"Chen JH, Wu CH, Jheng JR, Chao CT, Huang JW, Hung KY, et al. The down-regulation of XBP1, an unfolded protein response effector, promotes acute kidney injury to chronic kidney disease transition. J Biomed Sci. 2022;29:46.","journal-title":"J Biomed Sci"},{"key":"3264_CR147","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.addr.2017.12.019","volume":"129","author":"MV Nastase","year":"2018","unstructured":"Nastase MV, Zeng-Brouwers J, Wygrecka M, Schaefer L. Targeting renal fibrosis: Mechanisms and drug delivery systems. Adv Drug Deliv Rev. 2018;129:295\u2013307.","journal-title":"Adv Drug Deliv Rev"},{"key":"3264_CR148","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.kint.2019.08.028","volume":"97","author":"J Cai","year":"2020","unstructured":"Cai J, Liu Z, Huang X, Shu S, Hu X, Zheng M, et al. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking \u03b2-catenin target gene expression. Kidney Int. 2020;97:106\u201318.","journal-title":"Kidney Int"},{"key":"3264_CR149","doi-asserted-by":"crossref","unstructured":"Jin J, Li W, Wang T, Park BH, Park SK, Kang KP. Loss of proximal tubular sirtuin 6 aggravates unilateral ureteral obstruction-induced tubulointerstitial inflammation and fibrosis by regulation of \u03b2-catenin acetylation. Cells. 2022;11:1477.","DOI":"10.3390\/cells11091477"},{"key":"3264_CR150","doi-asserted-by":"publisher","first-page":"120914","DOI":"10.1016\/j.lfs.2022.120914","volume":"308","author":"J Cai","year":"2022","unstructured":"Cai J, Wang T, Zhou Y, Tang C, Liu Y, Dong Z. Phosphorylation by GSK-3\u03b2 increases the stability of SIRT6 to alleviate TGF-\u03b2-induced fibrotic response in renal tubular cells. Life Sci. 2022;308:120914.","journal-title":"Life Sci"},{"key":"3264_CR151","doi-asserted-by":"crossref","unstructured":"Zhang Y, Arzaghi H, Ma Z, Roye Y, Musah S. Epigenetics of hypertensive nephropathy. Biomedicines. 2024;12:2622.","DOI":"10.3390\/biomedicines12112622"},{"key":"3264_CR152","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/HJH.0000000000001170","volume":"35","author":"TM Seccia","year":"2017","unstructured":"Seccia TM, Caroccia B, Cal\u00f2 LA. Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms. J Hypertens. 2017;35:205\u201312.","journal-title":"J Hypertens"},{"key":"3264_CR153","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1039\/D0FO03467C","volume":"12","author":"Y Fan","year":"2021","unstructured":"Fan Y, Cheng J, Yang Q, Feng J, Hu J, Ren Z, et al. Sirt6-mediated Nrf2\/HO-1 activation alleviates angiotensin II-induced DNA DSBs and apoptosis in podocytes. Food Funct. 2021;12:7867\u201382.","journal-title":"Food Funct"},{"key":"3264_CR154","doi-asserted-by":"publisher","first-page":"e13296","DOI":"10.1111\/cpr.13296","volume":"55","author":"Z Chen","year":"2022","unstructured":"Chen Z, Liang W, Hu J, Zhu Z, Feng J, Ma Y, et al. Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1-Drp1 signalling pathway. Cell Prolif. 2022;55:e13296.","journal-title":"Cell Prolif"},{"key":"3264_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01399-4","volume":"22","author":"Y Hao","year":"2024","unstructured":"Hao Y, Fan Y, Feng J, Zhu Z, Luo Z, Hu H, et al. ALCAT1-mediated abnormal cardiolipin remodelling promotes mitochondrial injury in podocytes in diabetic kidney disease. Cell Commun Signal. 2024;22:26.","journal-title":"Cell Commun Signal"},{"key":"3264_CR156","doi-asserted-by":"publisher","first-page":"111858","DOI":"10.1016\/j.cellsig.2025.111858","volume":"133","author":"Y Hao","year":"2025","unstructured":"Hao Y, Hu J, Zhang Z, Guan Q, Wang J, Tao Y, et al. Sirt6 deficiency exacerbates angiotensin II-induced lipid nephrotoxicity by affecting PLD6-derived cardiolipin metabolism in podocytes. Cell Signal. 2025;133:111858.","journal-title":"Cell Signal"},{"key":"3264_CR157","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.7150\/thno.45003","volume":"10","author":"Q Yang","year":"2020","unstructured":"Yang Q, Hu J, Yang Y, Chen Z, Feng J, Zhu Z, et al. Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes. Theranostics. 2020;10:7465\u201379.","journal-title":"Theranostics"},{"key":"3264_CR158","unstructured":"Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39."},{"key":"3264_CR159","doi-asserted-by":"publisher","first-page":"675.e9","DOI":"10.1016\/j.urolonc.2017.08.016","volume":"35","author":"SU Jeh","year":"2017","unstructured":"Jeh SU, Park JJ, Lee JS, Kim DC, Do J, Lee SW, et al. Differential expression of the sirtuin family in renal cell carcinoma: aspects of carcinogenesis and prognostic significance. Urol Oncol. 2017;35:675.e9\u2013675.e15.","journal-title":"Urol Oncol"},{"key":"3264_CR160","doi-asserted-by":"publisher","first-page":"e15154","DOI":"10.7717\/peerj.15154","volume":"11","author":"LS Peng","year":"2023","unstructured":"Peng LS, Duan SL, Li RQ, Bai ZY, Ou CL, Wang JP. Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma. PeerJ. 2023;11:e15154.","journal-title":"PeerJ"},{"key":"3264_CR161","first-page":"2526","volume":"12","author":"Y Ding","year":"2019","unstructured":"Ding Y, Wu S, Huo Y, Chen X, Chai L, Wang Y, et al. Inhibition of Sirt6 suppresses tumor growth by inducing G1\/S phase arrest in renal cancer cells. Int J Clin Exp Pathol. 2019;12:2526\u201335.","journal-title":"Int J Clin Exp Pathol"},{"key":"3264_CR162","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3892\/ol.2021.12554","volume":"21","author":"J An","year":"2021","unstructured":"An J, Yang J, Yao Y, Lu K, Zhao Z, Yu M, et al. Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B-cell lymphoma 2. Oncol Lett. 2021;21:293.","journal-title":"Oncol Lett"},{"key":"3264_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408945","volume":"11","author":"C Duan","year":"2024","unstructured":"Duan C, Li B, Liu H, Zhang Y, Yao X, Liu K, et al. Sirtuin1 suppresses calcium oxalate nephropathy via inhibition of renal proximal tubular cell ferroptosis through PGC-1\u03b1-mediated transcriptional coactivation. Adv Sci (Weinh). 2024;11:e2408945.","journal-title":"Adv Sci (Weinh)"},{"key":"3264_CR164","doi-asserted-by":"publisher","first-page":"114302","DOI":"10.1016\/j.intimp.2025.114302","volume":"150","author":"L Zhang","year":"2025","unstructured":"Zhang L, Song Z, Mao X, Yang Y, Hou B, Chen Y, et al. SIRT6 attenuates calcium oxalate Nephrocalcinosis-induced renal inflammation and oxidative injury via activating NRF2 signaling. Int Immunopharmacol. 2025;150:114302.","journal-title":"Int Immunopharmacol"},{"key":"3264_CR165","doi-asserted-by":"publisher","first-page":"113864","DOI":"10.1016\/j.intimp.2024.113864","volume":"146","author":"L Zhang","year":"2025","unstructured":"Zhang L, Song Z, Mao X, Yang Y, Hou B, Chen Y, et al. The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage. Int Immunopharmacol. 2025;146:113864.","journal-title":"Int Immunopharmacol"},{"key":"3264_CR166","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1042\/CS20120190","volume":"124","author":"M Kitada","year":"2013","unstructured":"Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya D. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond). 2013;124:153\u201364.","journal-title":"Clin Sci (Lond)"},{"key":"3264_CR167","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202400469","volume":"9","author":"Y Lu","year":"2025","unstructured":"Lu Y, Yang J, Wu Q, Wang X. The role and molecular pathways of SIRT6 in senescence and age-related diseases. Adv Biol (Weinh). 2025;9:e2400469.","journal-title":"Adv Biol (Weinh)"},{"key":"3264_CR168","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1080\/15384101.2016.1152427","volume":"15","author":"N Zhang","year":"2016","unstructured":"Zhang N, Li Z, Mu W, Li L, Liang Y, Lu M, et al. Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-\u03baB signaling. Cell Cycle. 2016;15:1009\u201318.","journal-title":"Cell Cycle"},{"key":"3264_CR169","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.18632\/aging.101214","volume":"9","author":"W Huang","year":"2017","unstructured":"Huang W, Liu H, Zhu S, Woodson M, Liu R, Tilton RG, et al. Sirt6 deficiency results in progression of glomerular injury in the kidney. Aging (Albany NY). 2017;9:1069\u201383.","journal-title":"Aging (Albany NY)"},{"key":"3264_CR170","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","volume":"45","author":"H Miao","year":"2024","unstructured":"Miao H, Wang YN, Su W, Zou L, Zhuang SG, Yu XY, et al. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway. Acta Pharm Sin. 2024;45:137\u201349.","journal-title":"Acta Pharm Sin"},{"key":"3264_CR171","doi-asserted-by":"publisher","first-page":"104283","DOI":"10.1016\/j.phrs.2019.104283","volume":"146","author":"T Rao","year":"2019","unstructured":"Rao T, Tan Z, Peng J, Guo Y, Chen Y, Zhou H, et al. The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective. Pharm Res. 2019;146:104283.","journal-title":"Pharm Res"},{"key":"3264_CR172","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fphar.2020.00264","volume":"11","author":"X Fan","year":"2020","unstructured":"Fan X, Wei W, Huang J, Liu X, Ci X. Isoorientin attenuates cisplatin-induced nephrotoxicity through the inhibition of oxidative stress and apoptosis via activating the SIRT1\/SIRT6\/Nrf-2 pathway. Front Pharm. 2020;11:264.","journal-title":"Front Pharm"},{"key":"3264_CR173","doi-asserted-by":"publisher","first-page":"579178","DOI":"10.3389\/fphar.2020.579178","volume":"11","author":"X Fan","year":"2020","unstructured":"Fan X, Wei W, Huang J, Peng L, Ci X. Daphnetin attenuated cisplatin-induced acute nephrotoxicity with enhancing antitumor activity of cisplatin by upregulating SIRT1\/SIRT6-Nrf2 pathway. Front Pharm. 2020;11:579178.","journal-title":"Front Pharm"},{"key":"3264_CR174","doi-asserted-by":"publisher","first-page":"9035547","DOI":"10.1155\/2022\/9035547","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, Zhou L, Du Y, Li H, Feng L, Li X, et al. Polydatin attenuates cisplatin-induced acute kidney injury via SIRT6-mediated autophagy activation. Oxid Med Cell Longev. 2022;2022:9035547.","journal-title":"Oxid Med Cell Longev"},{"key":"3264_CR175","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1089\/dna.2023.0102","volume":"42","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu W, Liu Y, Zhang Z, Hu Y, Sun D, et al. Astragaloside IV inhibited podocyte pyroptosis in diabetic kidney disease by regulating SIRT6\/HIF-1\u03b1 axis. DNA Cell Biol. 2023;42:594\u2013607.","journal-title":"DNA Cell Biol"},{"key":"3264_CR176","doi-asserted-by":"publisher","first-page":"154276","DOI":"10.1016\/j.phymed.2022.154276","volume":"104","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wu Q, Wang H, Gao Y, Nie K, Tang Y, et al. Diosgenin protects against podocyte injury in early phase of diabetic nephropathy through regulating SIRT6. Phytomedicine. 2022;104:154276.","journal-title":"Phytomedicine"},{"key":"3264_CR177","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jgr.2022.11.006","volume":"47","author":"H Oh","year":"2023","unstructured":"Oh H, Cho W, Park SY, Abd El-Aty AM, Jeong JH, Jung TW. Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPAR\u03b4- or SIRT6-mediated suppression of inflammation and oxidative stress. J Ginseng Res. 2023;47:400\u20137.","journal-title":"J Ginseng Res"},{"key":"3264_CR178","doi-asserted-by":"publisher","first-page":"109986","DOI":"10.1016\/j.abb.2024.109986","volume":"755","author":"RA Elrashidy","year":"2024","unstructured":"Elrashidy RA, Mohamed HE, Abdel Aal SM, Mohamed SR, Tolba SM, Mahmoud YK. Oleuropein attenuates the nephrotoxic effect of sunitinib in rats: unraveling the potential role of SIRT6\/Notch-1\/NLRP-3\/IL-1\u03b2 axis. Arch Biochem Biophys. 2024;755:109986.","journal-title":"Arch Biochem Biophys"},{"key":"3264_CR179","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5301\/uro.5000148","volume":"82","author":"G Scaduto","year":"2015","unstructured":"Scaduto G, Daricello G, Pavone C. [Results of a single blind study placebo vs Diallil-Tiosulphinate, Nucipherine and Diosgenin in patients reponders to Tadalafil 5 mg]. Urologia. 2015;82:238\u201341.","journal-title":"Urologia"},{"key":"3264_CR180","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.tjnut.2025.02.015","volume":"155","author":"PJ Pinckaers","year":"2025","unstructured":"Pinckaers PJ, Petrick HL, Horstman AM, Moreno-Asso A, De Marchi U, Hendriks FK, et al. Oleuropein supplementation increases resting skeletal muscle fractional pyruvate dehydrogenase activity but does not influence whole-body metabolism: a randomized, double-blind, and placebo-controlled trial in healthy, older males. J Nutr. 2025;155:1373\u201386.","journal-title":"J Nutr"},{"key":"3264_CR181","doi-asserted-by":"publisher","first-page":"112397","DOI":"10.1016\/j.nut.2024.112397","volume":"122","author":"G Di Nardo","year":"2024","unstructured":"Di Nardo G, Bernardo L, Cremon C, Barbara G, Felici E, Evangelisti M, et al. Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial. Nutrition. 2024;122:112397.","journal-title":"Nutrition"},{"key":"3264_CR182","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cpdd.1488","volume":"14","author":"G Rigdon","year":"2025","unstructured":"Rigdon G, Prescott Y, Hall J, Abernathy K, Raskin J, Wargin W. Phase 1, single-center, double-blind, randomized, placebo-controlled studies of the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of the sirtuin 6 activator SP-624 in healthy adults. Clin Pharm Drug Dev. 2025;14:18\u201325.","journal-title":"Clin Pharm Drug Dev"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03264-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:07:07Z","timestamp":1791904027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":182,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3264"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03264-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"COMPETING INTERESTS","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"414"}}